Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus.

Li, Fang; Lei, Feifei; Wen, Chengcai; Ge, Qiu; Zhu, Liyao

Li, Fang; Lei, Feifei; Wen, Chengcai; Ge, Qiu; Zhu, Liyao.

Afiliação

Li F; Department of Infectious Diseases, Institute of Hepatic Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, China.
Lei F; Department of Infectious Diseases, Institute of Hepatic Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, China.
Wen C; Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Ge Q; Outpatient Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China. gq319329@163.com.
Zhu L; Department of Hepatology, The Fourth People's Hospital of Huai'an, Jiangsu, China. zhu_liyao@126.com.

BMC Gastroenterol ; 21(1): 391, 2021 Oct 20.

Article em En | MEDLINE | ID: mdl-34670509

Assuntos

Diabetes Mellitus Tipo 2; Hepatite C; Queratina-18/metabolismo; Diabetes Mellitus Tipo 2/complicações; Hepacivirus; Humanos; Cirrose Hepática/diagnóstico; Estudos Retrospectivos

Palavras-chave

Cytokeratin 18 (CK18); Hepatitis C virus (HCV); Liver fibrosis; Predictive values; Type 2 diabetes mellitus (T2DM)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Diabetes Mellitus Tipo 2 / Queratina-18 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google